A legal fight over a single amino acid could set retatrutide's exclusivity window, its Medicare negotiation clock, and its competitive future.
News|Articles|July 17, 2026
Hereditary Hemochromatosis: A Preventable Burden Hidden in Plain Sight
Author(s)Maggie L. Shaw
Fact checked by: Laura Joszt, MA
A common, underdiagnosed genetic disorder, hereditary hemochromatosis is costly when caught late and simple to treat when caught early.
Advertisement
Advertisement
One of the most common inherited genetic disorders in the US is quietly driving cirrhosis, heart failure, and diabetes as well as years of unnecessary specialist care, all largely preventable with a blood test and a timely diagnosis, according to Usha Perepu, MD, a nationally recognized classical hematology expert and director of classical hematology at the Mays Cancer Center at UT Health San Antonio.
Related to this article
Medicaid expansion was associated with lower colorectal cancer mortality, with the largest reductions in Hispanic patients and stage IV disease.
Amanda Velazquez, MD, discusses GLP-1 formulary strategies, overcoming prior authorization hurdles, and building scalable obesity care infrastructure.
Older adults on Medicare report the best access to care among 10 countries but more cost-related problems and higher out-of-pocket spending.
The study authors note there is an urgent need for "innovative value-based and alternative payment models of care."
The trade group says CMS lacks authority to impose GLOBE, which is set to begin January 1.
CMS finalized Transparency in Coverage updates as a researcher warns ghost rates and missing inpatient data limit payer price files.
Cepheid's Connie Savor, MD, MBA, explains where its 13-pathogen respiratory panel fits in diagnostic stewardship and antibiotic decisions.
Advertisement
Advertisement